CMTM5-v1, a four-transmembrane protein, presents a secreted form released via a vesicle-mediated secretory pathway

BMB Reports

Volumn 43, Issue 3, 2010, Pages 182-187

  Li, Henan ^a   Guo, Xiaohuan ^a   Shao, Luning ^a   Plate, Markus ^a   Mo, Xiaoning ^a   Wang, Yu ^a   Han, Wenling ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

CMTM; Secretion; TM4SF; Vesicles

Indexed keywords

EID: 77953497995     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2010.43.3.182     Document Type: Article

References (22)

1. Han, W., Lou, Y., Tang, J., Zhang, Y., Chen, Y., Li, Y., Gu, W., Huang, J., Gui, L., Tang, Y., Li, F., Song, Q., di C, Wang, L., Shi, Q., Sun, R., Xia, D., Rui, M., Tang, J. and Ma, D. (2001) Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity. Biochem. J. 357, 127-135.
2. Han, W., Ding, P., Xu, M., Wang, L., Rui, M., Shi, S., Liu, Y., Zheng, Y., Chen, Y., Yang, T. and Ma, D. (2003) Identification of eight genes encoding chemokine-like factor superfamily members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation. Genomics. 81, 609-617.
3. Jin, C., Wang, Y., Han, W., Zhang, Y., He, Q., Li, D., Yin, C., Tian, L., Liu, D., Song, Q. and Ma, D. (2007) CMTM8 induces caspase-dependent and -independent apoptosis through a mitochondria-mediated pathway. J. Cell Physiol. 211, 112-120.
4. Li, D., Jin, C., Yin, C., Zhang, Y., Pang, B., Tian, L., Han, W., Ma, D. and Wang, Y. (2007) An alternative splice form of CMTM8 induces apoptosis. Int. J. Biochem. Cell. Biol. 39, 2107-2119.
5. Li, T., Zhong, J., Chen, Y., Qiu, X., Zhang, T., Ma, D. and Han, W. (2006) Expression of chemokine-like factor 1 is upregulated during T lymphocyte activation. Life Sci. 79, 519-524.
6. Shao, L., Cui, Y., Li, H., Liu, Y., Zhao, H., Wang, Y., Zhang, Y., Ng, K. M., Han, W., Ma, D. and Tao, Q. (2007) CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines. Clin. Cancer Res. 13, 5756-5762.
7. Shao, L., Guo, X., Plate, M., Li, T., Wang, Y., Ma, D., and Han, W. (2009) CMTM5-v1 induces apoptosis in cervical carcinoma cells. Biochem. Biophys. Res. Commun. 379, 866-871.
8. Shi, S., Rui, M., Han, W., Wang, Y., Qiu, X., Ding, P., Zhang, P., Zhu, X., Zhang, Y., Gan, Q., and Ma, D. (2005) CKLFSF2 is highly expressed in testis and can be secreted into the seminiferous tubules. Int. J. Biochem. Cell. Biol. 37, 1633-1640.
9. Wang, Y., Li, J., Cui, Y., Li, T., Ng, K. M., Geng, H., Li, H., Shu, X. S., Li, H., Liu, W., Luo, B., Zhang, Q., Mok, T. S., Zheng, W., Qiu, X., Srivastava, G., Yu, J., Sung, J. J., Chan, A. T., Ma, D., Tao, Q. and Han, W. (2009) CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Res. 69, 5194-5201.
10. Wang, Y., Li, T., Qiu, X., Mo, X., Zhang, Y., Song, Q., Ma, D. and Han, W. (2008) CMTM3 can affect the transcription activity of androgen receptor and inhibit the expression level of PSA in LNCaP cells. Biochem. Biophys. Res. Commun. 371, 54-58.
11. Zhong, J., Wang, Y., Qiu, X., Mo, X., Liu, Y., Li, T., Song, Q., Ma, D. and Han, W. (2006) Characterization and expression profile of CMTM3/CKLFSF3. J. Biochem. Mol. Biol. 39, 537-545.
12. Guo, X., Li, T., Wang, Y., Shao, L., Zhang, Y., Ma, D. and Han, W. (2009) CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNF-alpha. Biochem. Biophys. Res. Commun. 387, 139-142.
13. Escola, J. M., Kleijmeer, M. J., Stoorvogel, W., Griffith, J. M., Yoshie, O. and Geuze, H. J. (1998) Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 273, 20121-20127.
14. Llorente, A., de Marco, M. C., and Alonso, M. A. (2004) Caveolin-1 and MAL are located on prostasomes secreted by the prostate cancer PC-3 cell line. J. Cell. Sci. 117, 5343-5351.
15. Nickel, W. (2003) The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur. J. Biochem. 270, 2109-2119.
16. Thery, C., Ostrowski, M. and Segura, E. (2009) Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581-593.
17. Miller, S. G., Carnell, L. and Moore, H. H. (1992) Post-Golgi membrane traffic: brefeldin A inhibits export from distal Golgi compartments to the cell surface but not recycling. J. Cell. Biol. 118, 267-283.
18. Fernandez-Borja, M., Wubbolts, R., Calafat, J., Janssen, H., Divecha, N., Dusseljee, S. and Neefjes, J. (1999) Multivesicular body morphogenesis requires phosphatidyl-inositol 3-kinase activity. Curr. Biol. 9, 55-58.
19. Islam, A., Shen, X., Hiroi, T., Moss, J., Vaughan, M. and Levine, S. J. (2007) The brefeldin A-inhibited guanine nucleotide-exchange protein, BIG2, regulates the constitutive release of TNFR1 exosome-like vesicles. J. Biol. Chem. 282, 9591-9599.
20. Sanchez-Pulido, L., Martin-Belmonte, F., Valencia, A. and Alonso, M. A. (2002) MARVEL: a conserved domain involved in membrane apposition events. Trends. Biochem. Sci. 27, 599-601.
21. Ronquist, G. and Brody, I. (1985) The prostasome: its secretion and function in man. Biochim. Biophys. Acta. 822, 203-218.
22. Carlsson, L., Lennartsson, L., Nilsson, B. O., Nilsson, S. and Ronquist, G. (2000) Growth-inhibitory effect of prostasomes on prostatic cancer cell lines in culture. Eur. Urol. 38, 468-474.